ERA7 PRESENTS ITS DEVELOPMENTS ON GENOMICS, MICROBIOME AND CANCER IN THE ONCONET-SUDOE EUROPEAN FORUM
The relationship between microbiota and the development and treatment of cancer is a hot topic in biomedical research. Recently, two studies published in the journal "Science" relate the effectiveness of immunotherapeutic treatments with composition of the intestinal microbiota.
Dr. Eduardo Pareja, Managing Director of Era7 Bioinformatics, has participated at the ONCO Emergence Forum recently held in Montpellier (France). These Conference on translational research and innovation in oncology is part of the ONCONET_SUDOE project in which the Health Technology Park of Granada (headquarters of Era7) is one of the partners.
Dr. Pareja has presented the range of Next Generation Sequencing (NGS) technologies offered by Era7 Bioinformatics in relation to immune-genomics and its relationship with the microbiome and cancer immunotherapy. Era7 Bioinformatics offers its IM7 immuno-genomics service as a natural complement to its NGS services focused on genomic bacteria and MG7 microbiome.